Austar Lifesciences Limited
AULSF
$0.02
-$0.05-71.43%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.41% | -13.66% | 325.97% | 319.86% | 113.93% |
| Total Depreciation and Amortization | -14.23% | -15.46% | -1.26% | -2.69% | 9.61% |
| Total Amortization of Deferred Charges | -2.34% | -3.76% | 13.64% | 12.01% | -9.91% |
| Total Other Non-Cash Items | 32.69% | 30.79% | 2.03% | 3.44% | -90.15% |
| Change in Net Operating Assets | 60.48% | 58.17% | -- | -- | 119.29% |
| Cash from Operations | 19.23% | 17.52% | 99.72% | 96.84% | 3,548.74% |
| Capital Expenditure | 19.56% | 20.71% | -102.54% | -99.64% | 56.86% |
| Sale of Property, Plant, and Equipment | -88.08% | -88.28% | -- | -- | 3,818.92% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.50% | -36.42% | -52.14% | -52.83% | -61.05% |
| Cash from Investing | -30.63% | -28.74% | -122.35% | -122.03% | 72.68% |
| Total Debt Issued | 43.49% | 43.49% | 11.50% | 11.50% | -29.03% |
| Total Debt Repaid | -22.75% | -22.75% | -0.40% | -0.40% | -27.71% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 7.43% | 7.43% | 25.46% | 25.46% | -9.66% |
| Cash from Financing | 55.88% | 56.51% | 31.69% | 32.67% | -170.25% |
| Foreign Exchange rate Adjustments | -165.15% | -164.38% | -143.53% | -142.74% | 1,520.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.33% | 133.92% | 90.98% | 91.11% | -28.92% |